CompletedNot Applicable

Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction

Brazil320 participantsStarted 2021-04-02

Plain-language summary

This study aims to find out whether taking antibiotics to prevent a urinary tract infection after a medical procedure called percutaneous nephrostomy (placement of a catheter directly into the kidney to keep it working after the urinary tract has been blocked by a malignant tumour) actually prevents a urinary tract infection, compared to not taking antibiotic prophylaxis.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients treated for cancer who required percutaneous nephrostomies Exclusion Criteria: * Patients and/or procedures if percutaneous nephrostomy was used to perform other procedures; * Patients and/or procedures if percutaneous nephrostomy was used to treat clinical conditions other than malignant ureteral obstruction * Patients and/or procedures if percutaneous nephrostomy was used to clear the urinary tract of non-malignant causes

What they're measuring

Urinary tract infection rate

Timeframe: Up to 7 days after percutaneous nephrostomy

Trial details

NCT IDNCT06801405

SponsorBarretos Cancer Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-10-10

View on ClinicalTrials.gov More Ureteral Obstruction trials